BioStructures' Signafuse Bioactive Bone Graft Putty has been used in 4,000 implantations.
Here are three facts:
1. Signafuse received FDA 510(k) clearance in 2014 as bone void filler for standalone use in posterolateral spine fusion procedures.
2. Signafuse is a moldable bone graft comprised of patented bioactive glass particles and biphasic mineral granules suspended in a patented resorbable polymer carrier.
3. BioStructures is a medical device company focused on developing proprietary platforms in bioresorbable bone graft products for a range of spinal and orthopedic fusion procedures.